| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |